Assignee
TERRAN BIOSCIENCES INC
US·11 granted patents·39 pending applications·4 citations·filing 2019–2025
Top patents by PatentIndex Score
50 records- 0190US11958821B2Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 16, 2024·2 cites·25 claims
- 0281US12577222B2Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2024·Granted Mar 17, 2026·0 cites·38 claims
- 0379US12435036B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2024·Granted Oct 7, 2025·0 cites·14 claims
- 0479US12079960B2Systems, devices, and methods for harmonization of imaging datasets including biomarkersTERRAN BIOSCIENCES INC·Filed 2022·Granted Sep 3, 2024·2 cites·18 claims
- 0579US2024409526A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0678US11945832B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 2, 2024·0 cites·18 claims
- 0776US2026008797A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0876US2026078090A1N-substituted indoles as 5-hydroxytryptamine (5-ht) serotonin receptor agonists and antagonistsTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0975US12319652B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 1075US12234216B2Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Feb 25, 2025·0 cites·14 claims
- 1175US11851452B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Dec 26, 2023·0 cites·28 claims
- 1275US2023202998A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1373US12269818B2Analogs of xanomelineTERRAN BIOSCIENCES INC·Filed 2024·Granted Apr 8, 2025·0 cites·42 claims
- 1473US2026000641A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (imdai)TERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1572US2024002337A1Salts and solid forms of (r)-1-(5-methoxy-1h-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1672US2025011351A1Psilocybin and o-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1772US2026085041A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1871US11905295B2Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2023·Granted Feb 20, 2024·0 cites·28 claims
- 1970US11866408B2N,N-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Jan 9, 2024·0 cites·28 claims
- 2069US2024317783A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2168US2023159456A1N-substituted indolesTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2268US2024116870A1N,n-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2368US2025066299A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2467US2026092060A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2567US2023150965A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2667US2023257385A1Salt and solid forms of tabernanthalogTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2766US2025109130A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2866US2024400512A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2966US2025034105A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3065US2023181521A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)TERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3165US2024294488A1Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3265US2023150936A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3365US2026007323A1Neuromelanin-sensitive mri for assessing parkinson's diseaseTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3461US2023159544A1Azepino-indoles for the treatment of neurological and psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3561US2025091993A1Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3660US2025129064A1Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide)TERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3760US2025195477A1Deuterated idazoxan and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3860US2025136548A1Functionalized alkylaminesTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3959US2025129054A1Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4059US2025049748A1Analogs of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4159US2023150966A1Isotopically enriched 3,4-methylenedioxy-n-ethylamphetamine (mde) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4253US2025011344A1Prodrugs and derivatives of psilocin and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4351US2024317724A13,4-methylenedioxymethamphetamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4450US2023150920A1Salts and solid forms of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4549US2022106272A1Deuterated Forms And Derivatives Of VolinanserinTERRAN BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 4648US2024197681A1Methods and compositions relating to psychedelics and serotonin receptor modulatorsTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4745US2022273184A1Neuromelanin-sensitive mri for assessing parkinson's diseaseTERRAN BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4845US2023389854A1Neuromelanin-sensitive mri and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4943US2024294460A1Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 5043US2024000795A1Methods and compositions relating to controlling psychedelic effects with serotonin receptor modulatorsTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →